Highlights From the American Heart Association's Scientific Sessions 2022
JAMA Medical News
00:00
Cardiovascular Effects of E-Cigarette Use or Vaping
There were similarly really striking findings in a preclinical study of CRISPR-based editing for PCSK9. A company's product that they're calling VIRV-101 is actually a CRisPR-Cas9-based therapy to try to target PCSK9 which is a very important pathway for how we handle LDL. And then switching gears, misinformation was a topic that received a lot of attention at the conference. One of the biggest threats, even though you can prove it, to our health is going to be misinformation.
Play episode from 16:03
Transcript
